[#DIV28SUPER] FDA science forum agenda (with substance use focus)

Hello colleagues,

Below is a link to public FDA meetings outlining their scientific agenda, which features a keynote address from Dr. Anthony Fauci and includes several other sessions with relevance to our field, including a session scheduled on May 27th with the following presentations:

Concurrent Session 8: Substance Use, Misuse, and Addiction
12:00p.m. – 2:00 p.m.
Virtual ADOBE Room
Session Chair/Moderator:  Marta Sokolowska, Ph.D.

Time	Presentation	Speaker
12:00 pm – 12:05 pm	Introduction	Marta Sokolowska, Ph.D. CDER/FDA
12:05 pm – 12:35 pm	Substance use disorders linked to COVID-19 susceptibility	Nora D. Volkow, M.D. Director, National Institute on Drug Abuse/National Institutes of Health (NIH)
12:35 pm – 12:50 pm	COVID-19 and the Opioid Crisis: A Social Media Perspective	Jill Settle, Ph.D.  CDER/FDA
12:50 pm – 1:05 pm	And the Kids Vaped on: Teens, Tobacco, and the National Youth Tobacco Survey	Karen Cullen, Ph.D., MPH CTP/FDA
1:05 pm – 1:20 pm	Investigation of Opioid Exposure and Neural Tube Defects – In Vivo and In Vitro Approaches	Amy Inselman, Ph.D. NCTR/FDA
1:20 pm – 1:35 pm	Tobacco and Cannabis – Did EVALI teach us anything?	Priscilla Callahan-Lyon, MD  CTP/FDA
1:35 pm – 2:00 pm	Panel Discussion/Q&A	Moderator: Marta Sokolowska, Ph.D. Nora Volkow, MD (NIH/NIDA)  Jill Settle, PhD (FDA/CDER) Karen Cullen, PhD (FDA/CTP)  Amy Inselman, PhD (FDA/NCTR) Priscilla Callahan-Lyon, MD (FDA/CTP)

The full agenda is available here: https://www.fda.gov/science-research/fda-science-forum/2021-fda-science-forum-agenda

And you can register here: https://www.fda.gov/science-research/about-science-research-fda/fda-science-forum

Warm regards

Kelly

---
Kelly Dunn, Ph.D., M.B.A.

President, Division on Psychopharmacology and Substance Use (Division 28)

American Psychological Association

Associate Professor
Behavioral Pharmacology Research Unit
Department of Psychiatry and Behavioral Sciences
Johns Hopkins School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
P:410-550-2254; F:410-550-0030